Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02119299 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of the SMART Device for Overweight and Obese Adults

A NA study of Overweight and Obesity, sponsored by Scientific Intake Limited.

Completed
Registry status
NA
Development phase
76
Enrollment target
4
Study locations

NCT02119299 is a NA study of Overweight and Obesity that has completed, run by Scientific Intake Limited. The registered enrollment target is 76 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02119299, a NA study of Overweight and Obesity, has completed, sponsored by Scientific Intake Limited.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to demonstrate that (1) we will observe at least 40% of the subjects in the Per Protocol population having a measured ≥5% weight loss at 16 weeks compared to week 0; and (2) the observed mean % Total Body Weight Loss at 16 weeks compared to Week 0 is ≥4% in the Per Protocol population.

Conditions Studied

Interventions

  • DEVICE SMART device

Study Locations (4)

California

  • Investigative Site - San Diego

Connecticut

  • Investigative Site - Waterbury

Florida

  • Investigative Site - Coral Gables

Texas

  • Investigative Site - Sugar Land

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2014-03
Est. Completion 2015-01
Phase NA

Sponsor

Scientific Intake Limited

1 total trials

What the Registry Record Tells You About NCT02119299

The ClinicalTrials.gov registry entry for NCT02119299 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% lower). The listed sponsor is Scientific Intake Limited, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 1 intervention - of which SMART device is the first listed.

NCT02119299 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Connecticut, Florida.

Frequently Asked Questions

What is clinical trial NCT02119299 about?

NCT02119299 is a clinical study titled "Safety and Efficacy of the SMART Device for Overweight and Obese Adults". The purpose of this study is to demonstrate that (1) we will observe at least 40% of the subjects in the Per Protocol population having a measured ≥5% weight loss at 16 weeks compared to week 0; and (2) the observed mean % Total Body Weight Loss at 16 weeks compared to Week 0 is ≥4% in the Per Proto...

What is the current status of trial NCT02119299?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2014-03. Estimated completion is 2015-01.

What conditions does trial NCT02119299 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT02119299?

The interventions under investigation include: SMART device (DEVICE).

Who is sponsoring clinical trial NCT02119299?

This trial is sponsored by Scientific Intake Limited, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02119299 being conducted?

This trial has 4 study locations across California, Connecticut, Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.